Search results
A new beginning to better our world with biology. Novozymes and Chr. Hansen have joined forces to create Novonesis, a leading biosolutions partner. Working closely with our customers, we’re transforming how the world produces, consumes and lives.
- Food Cultures & Enzymes
Chr. Hansen supplies cultures, enzymes and probiotics for...
- Human Health & Probiotics
Founded on science almost 150 years ago in Denmark, Chr....
- HMO
Scientific data indicates that each HMO may bring a unique...
- About us
Chr. Hansen is a global, differentiated bioscience company...
- Food Cultures & Enzymes
Chr. Hansen A/S is a bioscience company based in Hørsholm, Denmark. Since January 2024 together with Novozymes a part of Novonesis. [4] The company is a supplier of bacteria cultures, probiotics, enzymes [1] and human milk oligosaccharides.
Dec 13, 2023 · Novonesis is the name chosen by Novozymes and Chr. Hansen for their combined company, which will offer biosolutions for various industries. The merger is expected to complete in the first quarter of 2024 and will create a global leader in biological innovation.
- Novozymes A/S
Dec 12, 2022 · The two Danish companies have agreed to combine through a statutory merger, aiming to unleash the full potential of biological solutions and generate significant value for all stakeholders and society. The proposed transaction is supported by Novo Holdings, the largest shareholder in both Novozymes and Chr. Hansen, and is expected to create a global leader in biosolutions with a broad portfolio and a customer-centric approach.
- Novozymes A/S
Chr. Hansen is a Danish company that produces natural ingredients and biosolutions for various industries. It merged with Novozymes in 2024 to form Novonesis, a global leader in biotechnology research.
at Chr. Hansen we are working determinedly on managing our own emissions throughout the value chain to reduce our ‘footprint’, it is our ‘handprint’ that sets us apart as a global bioscience company.